Spectral AI (MDAI) Stock Price, News & Analysis

Company Overview

Spectral AI, Inc. is a medical technology company focused on using artificial intelligence and multispectral imaging to improve the assessment and treatment of wounds. The company develops noninvasive diagnostic tools designed to provide clinicians with objective information about wound severity and healing potential.

Its principal product is the DeepView Wound Imaging System, which is being developed to support the evaluation of burns and diabetic foot ulcers. By analyzing wound images and related tissue characteristics, the system is intended to help healthcare professionals identify wounds that may heal on their own and those that may require additional intervention.

Spectral AI, formerly known as Spectral MD, has developed its technology for use in hospital and clinical settings. The company is headquartered in Dallas, Texas, and its programs have included collaborations and support involving U.S. government and healthcare organizations. The DeepView platform remains central to Spectral AI’s efforts to commercialize AI-assisted wound diagnostics.

Key Stats

• Today's Range: $1.63 to $1.71
• 50-Day Range: $1.50 to $1.75
• 52-Week Range: $1.18 to $2.97
• Volume: 161,889 shs
• Average Volume: 500,328 shs
• Market Capitalization: $53.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $4.00
• Consensus Rating: Moderate Buy

Spectral AI Stock Analysis - MarketRank™

Spectral AI scored higher than 29% of companies evaluated by MarketBeat, and ranked 697th out of 895 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Spectral AI has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 1 strong buy rating, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Spectral AI has a consensus price target of $4.00, representing about 136.0% upside from its current price of $1.70.

Amount of Analyst Coverage

Spectral AI has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Spectral AI are expected to grow in the coming year, from ($0.50) to ($0.36) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Spectral AI is -4.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Spectral AI is -4.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

8.05% of the float of Spectral AI has been sold short.

Short Interest Ratio / Days to Cover

Spectral AI has a short interest ratio ("days to cover") of 16.43, which indicates bearish sentiment.

Change versus previous month

Short interest in Spectral AI has recently increased by 6.24%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Spectral AI does not currently pay a dividend.

Dividend Growth

Spectral AI does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Spectral AI this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Spectral AI insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.70% of the stock of Spectral AI is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

67.08% of the stock of Spectral AI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/11/2026
• Today: 9/21/2026
• Next Earnings (Estimated): 11/10/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:MDAI
• CIK: 1833498
• Web: www.spectral-ai.com
• Phone: 212-492-3000
• Fax: N/A
• Employees: 65
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Spectral AI: $4.00
• High Price Target: $4.00
• Low Price Target: $4.00
• Potential Upside/Downside: +138.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.35)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.57 million
• Net Margins: -69.27%
• Pretax Margin: -65.78%
• Return on Equity: N/A
• Return on Assets: -78.56%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.90
• Quick Ratio: 0.85

Sales & Book Value

• Annual Sales: $19.65 million
• Price / Sales: 2.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.19) per share
• Price / Book: -8.82

Miscellaneous

• Outstanding Shares: 32,190,000
• Free Float: 27,776,000
• Market Cap: $53.92 million
• Optionable: Not Optionable
• Beta: 1.18